Oct 19, 2020 7:30am EDT Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange
Oct 16, 2020 4:01pm EDT Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange
Oct 14, 2020 7:30am EDT Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities
Oct 07, 2020 7:30am EDT Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin
Sep 30, 2020 1:26pm EDT Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today
Sep 24, 2020 7:30am EDT Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
Sep 17, 2020 7:30am EDT Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management
Sep 15, 2020 7:00am EDT Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets